Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Fangyi Zhao, Ziqian Cheng, Jingjing Piao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Possible role of exercise therapy on depression: Effector neurotransmitters as key players
Hamed Alizadeh Pahlavani
Behavioural Brain Research (2023) Vol. 459, pp. 114791-114791
Closed Access | Times Cited: 53
Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Daniela-Mădălina Ciucă Anghel, Gabriela Viorela Nițescu, Andreea Taisia Tiron, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4969-4969
Open Access | Times Cited: 28
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
Intranasal Delivery of Near‐Infrared and Magnetic Dual‐Response Nanospheres to Rapidly Produce Antidepressant‐Like and Cognitive Enhancement Effects
Jiangnan Hu, Zhenglong Lian, Zhenzhen Weng, et al.
Advanced Materials (2024) Vol. 36, Iss. 31
Open Access | Times Cited: 6
Multi-detection of seratonin and dopamine based on an electrochemical aptasensor
Sare Nur Çuhadar, Habibe Durmaz, Nimet Yildirim-Tirgil
Chemical Papers (2024) Vol. 78, Iss. 12, pp. 7175-7185
Closed Access | Times Cited: 6
Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis
Antonio Tundo, Sophia Betrò, Rocco de Filippis, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1043-1043
Open Access | Times Cited: 15
Treatment of Depression with Acupuncture Based on Pathophysiological Mechanism
Bo Sun, Xue‐Wei Cao, Xin Ming, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 347-357
Open Access | Times Cited: 4
Beyond pain: The surprising connection between tramadol and depression
Kaiqin Chen, Hong Wu, Yingbing Fang
Psycho-Oncologie (2025) Vol. 19, Iss. 1, pp. 3628-3628
Closed Access
Neurotransmitter and metabolic effects of interferon-alpha in association with decreased striatal dopamine in a Non-Human primate model of Cytokine-Induced depression
Mandakh Bekhbat, Andrew M. Block, Sarah Y. Dickinson, et al.
Brain Behavior and Immunity (2025)
Closed Access
Computational Approaches to Drug Discovery in Depression
Kalpesh R. Patil, Aman B. Upaganlawar, Akhil Nagar, et al.
(2025), pp. 409-436
Closed Access
Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson’s Disease—Potential Biomarkers and Therapeutic Targets
K. Kawahata, Kohji Fukunaga
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17037-17037
Open Access | Times Cited: 6
Designing multi-target drugs for the treatment of major depressive disorder
Amit Kumar Halder, Soumya Mitra, M. Natália D. S. Cordeiro
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 6, pp. 643-658
Closed Access | Times Cited: 4
Tardive dyskinesia in Asia— current clinical practice and the role of neurologists in the care pathway
Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Huifang Shang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Identification of Key Genes and Imbalanced SNAREs Assembly in the Comorbidity of Polycystic Ovary Syndrome and Depression
Yi Cao, Weijing Wang, Xuxia Song, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 494-494
Open Access | Times Cited: 1
Comparative Short and Long-Term Effectiveness and Safety of Pramipexole and Aripiprazole Augmentation in Treatment Resistant Unipolar Depression. An Observational-Retrospective Study
Antonio Tundo, Sophia Betrò, Rocco de Filippis, et al.
(2024)
Open Access | Times Cited: 1
Mental health update – update on depression with a focus on escitalopram
Phumzile Skosana, N Shirindza, Veena Abraham
SA pharmaceutical journal. (2024) Vol. 91, Iss. 4, pp. 19-25
Closed Access | Times Cited: 1
Design and Synthesis of Potential Multi-Target Antidepressants: Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter
Martyna Z. Wróbel, Andrzej Chodkowski, Agata Siwek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11276-11276
Open Access | Times Cited: 1
Chronic unpredictable stress induces depression/anxiety-related behaviors and alterations of hippocampal monoamine receptor mRNA expression in female mice at different ages
Han Zhou, Kaixin Wang, Zhicheng Xu, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18369-e18369
Open Access | Times Cited: 3
Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch‐Lutwin, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 175-175
Open Access | Times Cited: 2
Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors
Sara C. Silva-Reis, Xavier Cruz Correia, Hugo F. Costa-Almeida, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1656-1663
Closed Access | Times Cited: 2
The effectiveness of off-label dopamine stimulating agents in depressive disorder: A systematic review and meta-analysis
Hans W. Jeuring, Emile d’Angremont, Joey M.H. Tol, et al.
Psychiatry Research (2022) Vol. 319, pp. 115010-115010
Open Access | Times Cited: 4
Unraveling the potential of Morinda officinalis oligosaccharides as an adjuvant of escitalopram in depression treatment and exploring the underlying mechanisms
Shu‐Man Pan, Xuyuan Yin, D. N. Dai, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118124-118124
Closed Access
Dopaminergic Modulation and Computational ADMET Insights for the Antidepressant-like Effect of N-(3-(Phenylselanyl)prop-2-yn-1-yl)benzamide
Evelyn Mianes Besckow, Kauane Nayara Bahr Ledebuhr, Camila Simões Pires, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1904-1914
Closed Access
A Transcriptomic Evaluation of Neuroactive Receptors in the Colon of a Dextran Sodium Sulphate Pig Model of Colitis
Marion T. Ryan, J.V. O’Doherty, Torres Sweeney
Nutraceuticals (2024) Vol. 4, Iss. 3, pp. 395-408
Open Access
Comparative Short- and Long-Term Effectiveness and Safety of Pramipexole and Aripiprazole Augmentation in Treatment-Resistant Unipolar Depression: An Observational Study
Antonio Tundo, Sophia Betrò, Rocco de Filippis, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2064-2064
Open Access
Page 1 - Next Page

Scroll to top